Division of Liver Diseases, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom.
Liver Transpl. 2020 Jul;26(7):916-921. doi: 10.1002/lt.25783.
Although liver transplantation (LT) for alcohol-associated liver disease (ALD) is a well-accepted practice, LT for severe alcoholic hepatitis (AH) remains controversial due to concerns about the limited organ supply and the risk of return to harmful drinking. Recognizing an increasing body of favorable evidence, a convergence of practice guideline recommendations from leading hepatology and gastroenterology societies have suggested that the length of abstinence should not be a sole criterion for LT selection and, thus, that LT may be considered in carefully selected severe AH patients with favorable psychosocial profiles not responding to medical therapy. We sought to examine this new consensus in greater detail, debating whether candidate selection criteria for LT in AH should be tightened or loosened.
虽然肝移植(LT)治疗酒精相关性肝病(ALD)已被广泛接受,但由于对器官供应有限和重新饮酒风险的担忧,LT 治疗严重酒精性肝炎(AH)仍存在争议。鉴于越来越多的有利证据,领先的肝脏病学和胃肠病学学会的实践指南建议趋同,表明不应将戒酒时间长短作为 LT 选择的唯一标准,因此,对于那些对药物治疗无反应且具有良好社会心理特征的重度 AH 患者,可考虑进行 LT。我们旨在更详细地研究这一新的共识,探讨在 AH 中 LT 的候选者选择标准是否应该收紧或放宽。